Anthony Mikulaschek

Anthony Mikulaschek, Vice President of Commercial Strategy at IQVIA Technologies, brings over 30 years of expertise in clinical trial technology. He discusses the evolution of electronic clinical outcome assessments (eCOAs) and their critical role in oncology. Mikulaschek highlights how AI enables real-time patient data capture, easing burdens for both patients and clinicians. He also delves into the importance of cultural and linguistic nuances in global trials and how compliance automation accelerates research, ultimately enhancing patient experiences.